John Aston
Net worth: 79 702 $ as of 31/05/2024
Career history of John Aston
Former positions of John Aston
Companies | Position | Start | End |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | Director/Board Member | 24/02/2011 | 12/12/2017 |
Chairman | 12/12/2017 | 11/12/2019 | |
Independent Dir/Board Member | 23/02/2011 | 11/12/2019 | |
POLAR CAPITAL GLOBAL HEALTHCARE TRUST PLC | Director/Board Member | 12/05/2010 | 28/02/2018 |
Independent Dir/Board Member | 12/05/2010 | 28/02/2018 | |
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Director of Finance/CFO | 01/01/2007 | 01/05/2010 |
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Director of Finance/CFO | 01/09/1996 | 30/06/2006 |
Calchan Holdings Ltd.
Calchan Holdings Ltd. Pharmaceuticals: MajorHealth Technology Calchan Holdings Ltd. develops novel oral state-dependent calcium channel modulators for chronic pain. The company was founded on February 25, 2011 and is headquartered in London, the United Kingdom. | Director/Board Member | - | - |
SCHRODERS PLC | Corporate Officer/Principal | - | - |
Calchan Ltd.
Calchan Ltd. BiotechnologyHealth Technology Calchan Ltd. operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain. The company was founded by Brenda Elizabeth Reynolds in 2011 and is headquartered in London, the United Kingdom. | Director/Board Member | - | - |
Steering Group | Corporate Officer/Principal | - | - |
Convergence Pharmaceuticals Ltd.
Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | - | - |
░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of John Aston
University of Cambridge | Undergraduate Degree |
Statistics
International
United Kingdom | 12 |
Finland | 2 |
Operational
Director/Board Member | 6 |
Corporate Officer/Principal | 3 |
Director of Finance/CFO | 2 |
Sectoral
Health Technology | 8 |
Miscellaneous | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SCHRODERS PLC | Finance |
Private companies | 10 |
---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
BTG Ltd.
BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
Regenerative Medicine Assets Ltd.
Regenerative Medicine Assets Ltd. Pharmaceuticals: MajorHealth Technology Regenerative Medicine Assets Ltd. engaged in the healthcare business. The company was founded by Paul Kemp in 2000 and was headquartered in Bristol, the United Kingdom. | Health Technology |
International Biotechnology Trust Plc
International Biotechnology Trust Plc Investment Trusts/Mutual FundsMiscellaneous International Biotechnology Trust Plc is a closed end investment trust company, which invests in the development staged biotechnology and other life sciences industries. The company was founded on January 1, 1994 and is headquartered in London, the United Kingdom. | Miscellaneous |
Polar Capital Global Healthcare Trust Plc
Polar Capital Global Healthcare Trust Plc Investment Trusts/Mutual FundsMiscellaneous Polar Capital Global Healthcare Trust Plc is an investment company. Its portfolio includes healthcare stocks across all four healthcare sub-sectors. The company was founded on May 12, 2010 and is headquartered in London, the United Kingdom. | Miscellaneous |
Convergence Pharmaceuticals Ltd.
Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Steering Group | |
Calchan Ltd.
Calchan Ltd. BiotechnologyHealth Technology Calchan Ltd. operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain. The company was founded by Brenda Elizabeth Reynolds in 2011 and is headquartered in London, the United Kingdom. | Health Technology |
Calchan Holdings Ltd.
Calchan Holdings Ltd. Pharmaceuticals: MajorHealth Technology Calchan Holdings Ltd. develops novel oral state-dependent calcium channel modulators for chronic pain. The company was founded on February 25, 2011 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- John Aston
- Experience